Amicus Therapeutics
FOLD
$10.28
Share price
1.08%
Change (1 day)
-9.82%
Change (1 year)
Categories
Amicus Therapeutics (FOLD) - P/B ratio
P/B ratio as of April 2024 : 19.0
According to Amicus Therapeutics
's latest financial reports the company has a price-to-book ratio of 19.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Amicus Therapeutics - P/B ratio (from 2007 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 26.0 | -6.81% |
| 2022-12-31 | 27.9 | 166.26% |
| 2021-12-31 | 10.5 | -50.17% |
| 2020-12-31 | 21.0 | 302.36% |
| 2019-12-31 | 5.22 | -1.31% |
| 2018-12-31 | 5.29 | -21.97% |
| 2017-12-31 | 6.78 | 245.24% |
| 2016-12-31 | 1.96 | -43.67% |
| 2015-12-31 | 3.49 | -46.42% |
| 2014-12-31 | 6.51 | 104.41% |
| 2013-12-31 | 3.18 | 65.66% |
| 2012-12-31 | 1.92 | -52.3% |
| 2011-12-31 | 4.03 | 61.28% |
| 2010-12-31 | 2.50 | 99.34% |
| 2009-12-31 | 1.25 | -49.83% |
| 2008-12-31 | 2.50 | 7.93% |
| 2007-12-31 | 2.31 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | 35.9 | 88.58% | 🇩🇰 Denmark |
 Biogen BIIB | 2.06 | -89.19% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 5.16 | -72.84% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | 2.79 | -85.34% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -0.7910 | -104.16% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.11 | -83.67% | 🇺🇸 USA |